Emily Pond

Researchers described the obstetric outcomes, based on COVID-19 vaccination status, in pregnant women with rheumatic and musculoskeletal diseases.

Researchers assessed the efficacy of rituximab and cyclophosphamide in the treatment of mixed connective tissue disease-related interstitial lung disease.

Researchers assessed the prevalence of prolonged COVID-19 symptom duration among patients with systemic autoimmune rheumatic diseases.

Investigators sought to find out if the psychiatric effects of the COVID-19 pandemic were more strongly pronounced in individuals with lower economic and personal capital.

Researchers investigated the seroreactivity of COVID-19 vaccination and adverse events among patients with systemic lupus erythematosus and rheumatoid arthritis.

Researchers sought to determine the outcomes among pediatric patients with rheumatic disease and COVID-19.

Researchers sought to determine whether patients with celiac disease are at increased risk for HBV infection despite having received HBV vaccination.

Researchers investigated HCV’s burden in 2020 and projected global burden for 2030.

Independent risk factors for pressure ulcers in ICU patients admitted with COVID-19 are identified from patient data.

Investigators assessed the impact of underlying comorbidities on the efficacy of fecal microbiota transplantation in children with recurrent Clostridioides difficile infection.